in haematologically normal tumor patients ~10%: in patients with active Hodgkin's disease 13.5%-55% %
||Human Homo sapiens
||Schick P, et al., Autotransfusion of 3H-cytidine-labelled blood lymphocytes in patients with Hodgkin's disease and non-Hodgkin patients. II. Exchangeable lymphocyte pools. Acta Haematol. 1975 53(4):206-18. p.213 bottom paragraphPubMed ID808930
|| Schnappauf H, Schnappauf U. [Drainage of the thoracic duct and amount of the "easily mobilized" lymphocytes in calves, sheep and dogs]. Blut. 1968 Jan16(4):209-20.PubMed ID5655805
||Abstract: "The dilution in the circulating blood of lymphocytes lablled in vitro with 3H-cytidine was examined after autotransfusion in 9 patients with Hodgkin's disease (HD) stage II A-IV B, 5 of whom were untreated in 2 untreated patients with carcinoma, and in 1 treated patient with scleroderma."
||P.213 bottom paragraph: "On the basis of data from 3H-thymidine labelling in vivo it was deduced that the proportion of short-lived small blood lymphocytes was about 10% in haematologically normal tumor patients [unpublished data] and 13.5-55% in patients with active Hodgkin’s disease [primary source]."